Kelli Borland, NP is a nurse practitioner in Fayetteville, GA with 7 years of experience. The provider is (1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners. Kelli Borland, NP NPI is 1144731951. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
The provider's business location address is:
101 YORKTOWN DR STE 207
FAYETTEVILLE, GA
ZIP 30214-578
Phone: (770) 460-4283
Fax: (770) 460-4074
The NPI 1144731951 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Destruction of 2-14 skin growths (HCPCS:17003)
- Destruction of skin growth (HCPCS:17000)
- Tangential biopsy of single skin lesion (HCPCS:11102)
- Tangential biopsy of additional skin lesion (HCPCS:11103)
- Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
- Destruction of up to 14 skin growths (HCPCS:17110)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
The enumeration date for this NPI number is 10/19/2017 and was last updated on 3/31/2023.